Xiaoyuan Chen Selected Research

4- fluorobenozyl- glutamyl- cyclo(arginyl- glycyl- aspartyl- tyrosyl- lysyl)2

1/2006

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyuan Chen Research Topics

Disease

639	Neoplasms (Cancer) 05/2024 - 01/2004
55	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2004
39	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2004
25	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 11/2004
25	Inflammation (Inflammations) 03/2024 - 11/2007
24	Glioma (Gliomas) 01/2024 - 02/2004
24	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 08/2004
18	Hypoxia (Hypoxemia) 10/2023 - 09/2008
16	Brain Neoplasms (Brain Tumor) 06/2019 - 01/2004
12	Melanoma (Melanoma, Malignant) 01/2024 - 04/2007
11	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023 - 10/2015
11	Insulinoma 04/2021 - 10/2011
9	Carcinoma (Carcinomatosis) 04/2024 - 06/2008
9	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 07/2012
9	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 02/2007
8	Stroke (Strokes) 03/2024 - 01/2008
8	Ischemia 03/2024 - 05/2007
7	Lung Neoplasms (Lung Cancer) 04/2024 - 03/2005
7	Hyperthermia 10/2020 - 01/2014
6	Bites and Stings (Sting) 05/2024 - 01/2020
6	Neuroinflammatory Diseases 03/2024 - 07/2014

Drug/Important Bio-Agent (IBA)

96	IntegrinsIBA 02/2024 - 01/2004
92	Peptides (Polypeptides)IBA 01/2024 - 01/2004
44	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2008
44	Integrin alphaVbeta3IBA 02/2010 - 01/2004
43	arginyl-glycyl-aspartic acidIBA 02/2024 - 01/2004
28	LigandsIBA 04/2024 - 03/2005
28	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2023 - 01/2004
26	Radioisotopes (Radionuclides)IBA 05/2024 - 01/2004
25	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 01/2016
25	GoldIBA 12/2021 - 04/2011
24	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2024 - 05/2014
23	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 04/2007
22	AntigensIBA 02/2024 - 10/2011
22	Contrast MediaIBA 01/2022 - 11/2004
20	Bombesin Receptors (Bombesin Receptor)IBA 02/2024 - 03/2006
20	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2006
18	AcidsIBA 07/2023 - 10/2004
18	EnzymesIBA 06/2023 - 12/2009
18	Cell Adhesion MoleculesIBA 07/2012 - 01/2004
17	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2024 - 05/2008
17	ProdrugsIBA 10/2023 - 01/2017
17	Photosensitizing Agents (Photosensitizers)IBA 12/2021 - 06/2011
17	cyclic arginine-glycine-aspartic acid peptideIBA 09/2012 - 01/2004
16	BombesinIBA 02/2024 - 08/2004
15	Small Interfering RNA (siRNA)IBA 01/2023 - 09/2006
15	Coloring Agents (Dyes)IBA 03/2020 - 11/2004
14	Glutathione (Reduced Glutathione)IBA 04/2024 - 02/2016
14	IonsIBA 04/2024 - 01/2016
14	AlbuminsIBA 12/2023 - 07/2014
14	Therapeutic UsesIBA 11/2023 - 08/2010
14	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2006
14	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2008
13	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 01/2011
13	Oxygen (Dioxygen)IBA 04/2024 - 01/2017
13	Evans Blue (Blue, Evans)FDA Link 01/2023 - 07/2009
13	ErbB Receptors (EGF Receptor)IBA 04/2019 - 06/2007
12	VaccinesIBA 04/2024 - 01/2017
12	NanovaccinesIBA 02/2024 - 03/2016
12	PolymersIBA 02/2024 - 10/2016
12	Matrix Metalloproteinases (MMPs)IBA 05/2020 - 11/2006
11	RadiopharmaceuticalsIBA 12/2023 - 12/2006
11	Firefly LuciferasesIBA 01/2017 - 11/2006
10	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 12/2014
10	MetalsIBA 02/2024 - 01/2016
10	AntibodiesIBA 03/2023 - 12/2005
10	Monoclonal AntibodiesIBA 11/2017 - 09/2006
10	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2012 - 11/2006
10	Integrin alphaVIBA 05/2008 - 01/2004
9	RNA (Ribonucleic Acid)IBA 03/2024 - 05/2014
9	MicellesIBA 02/2024 - 04/2011
9	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2019
9	Hydroxyl RadicalIBA 01/2023 - 08/2012
9	IronIBA 12/2021 - 02/2011
9	Exenatide (Byetta)FDA Link 04/2021 - 01/2012
8	CytokinesIBA 05/2024 - 02/2015
8	Peptide Receptors (Peptide Receptor)IBA 12/2023 - 10/2005
8	Chelating AgentsIBA 01/2018 - 06/2007
8	Ferritins (Ferritin)IBA 01/2018 - 02/2011
8	Fluorescent Dyes (Fluorescent Probes)IBA 01/2017 - 11/2004
7	Molecular Probes (Molecular Probe)IBA 05/2024 - 05/2007
7	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 02/2005
7	alfatide IIIBA 01/2022 - 04/2012
7	Glucagon-Like Peptide-1 ReceptorIBA 04/2021 - 01/2012
7	Metal-Organic FrameworksIBA 10/2020 - 01/2017
7	CopperIBA 01/2020 - 03/2016
7	Carbon Nanotubes (Carbon Nanotube)IBA 05/2014 - 08/2008

Therapy/Procedure

297	Therapeutics 05/2024 - 01/2004
99	Precision Medicine 04/2024 - 01/2008
53	Immunotherapy 05/2024 - 04/2010
52	Drug Therapy (Chemotherapy) 02/2024 - 09/2006
41	Photochemotherapy (Photodynamic Therapy) 02/2024 - 08/2013
36	Lasers (Laser) 01/2024 - 02/2008
32	Photothermal Therapy 02/2024 - 05/2013
26	Radiotherapy 02/2024 - 09/2006
25	Intravenous Injections 01/2023 - 01/2006
11	Intravenous Administration 01/2023 - 01/2006
10	Phototherapy (Light Therapy) 02/2024 - 01/2016
10	Aftercare (After-Treatment) 01/2019 - 03/2007
8	Quantum Dots (Quantum Dot) 03/2020 - 04/2006